Clariant Ag · SIX:CLN

Clariant — Q3 2022 Earnings Presentation

23 slides from Clariant's earnings presentation, Oct 27, 2022

  1. Slide 1: Third Quarter / Nine Month Figures 2022

    Third Quarter / Nine Month Figures 2022 Analyst Presentation 27.10.2022

  2. Slide 2: Disclaimer

    2 Third Quarter / Nine Month Figures 2022 27.10.2022 Disclaimer This presentation contains certain statements that are neither fluctuations, inflation, and consumer confidence, on a global, reported financial results nor other historical information. regional, or national basis. This presentation al

  3. Slide 3: Third Quarter 2022

    CLARIANT™ Third Quarter 2022 what is precious to you?

  4. Slide 4: Continued Strong Sales Growth in Q3 2022

    4 Third Quarter / Nine Month Figures 2022 27.10.2022 Continued Strong Sales Growth in Q3 2022… …18 % Price Contribution to Specialty Portfolio Growth 1 Q3 sales (continuing operations) up + 27 % in LC1 – + 18 % price contribution fully countered continued cost inflation – + 9 % volume increase2 Sale

  5. Slide 5: Third Quarter 2022 – Group Overview

    5 Third Quarter / Nine Month Figures 2022 27.10.2022 Third Quarter 2022 – Group1 Overview Geographic split – Europe with strong sales growth due to pricing in Care Chemicals and Natural Resources. Notable volume decline in Catalysis and slight decline in Care Chemicals and Natural Resources Sales CH

  6. Slide 6: Continued Strong Growth in Q3 2022, Delivered Profitability Improvement

    6 Third Quarter / Nine Month Figures 2022 27.10.2022 Continued Strong Growth in Q3 2022… …Delivered Profitability Improvement 2 Q3 EBITDA margin increased to 16.8 % – Q3 EBITDA improved by 130 basis points, driven by pricing measures, higher volumes, and cost savings EBITDA in CHF m – + 18 % pricing

  7. Slide 7: Executed Strategic Priorities

    7 Third Quarter / Nine Month Figures 2022 27.10.2022 Executed Strategic Priorities 3 Issuance of first green bond 4 Investment in China 5 Portfolio Pruning – In Q3 2022, Clariant placed its first ever – CHF 40 million investment in second line for – Divestment of North American Land Oil green bond (

  8. Slide 8: ESG – Clariant's Sustainability Transformation Commitment

    8 Third Quarter / Nine Month Figures 2022 27.10.2022 ESG – Clariant’s Sustainability Transformation Commitment Sustainability priorities Investment in operations & portfolio Fighting Climate Change Increasing Circularity Sustainable Reducing our own carbon Products and solutions that enable footprin

  9. Slide 9: ESG – Pioneering Technology for Steam Methane Reforming

    9 Third Quarter / Nine Month Figures 2022 27.10.2022 ESG – Pioneering Technology for Steam Methane Reforming A breakthrough in sustainable hydrogen production Clariant’s catalysis expertise has resulted in »EARTH®« Fighting Climate Change (Enhanced Annular Reforming Tube for Hydrogen), an innovative

  10. Slide 10: Third Quarter 2022 – Group Overview

    10 Third Quarter / Nine Month Figures 2022 27.10.2022 Third Quarter 2022 – Group1,2 Overview in CHF m Q3 2022 Q3 2021 % CHF % LC3 9M 2022 9M 2021 % CHF % LC3 Business Area composition1 (in %) Sales 1 312 1 096 + 20 + 27 3 875 3 130 + 24 + 29 EBITDA 220 170 + 29 656 506 + 30 Sales EBITDA EBITDA margi

  11. Slide 11: Third Quarter 2022 – Care Chemicals

    11 Third Quarter / Nine Month Figures 2022 27.10.2022 Third Quarter 2022 – Care Chemicals1 in CHF m Q3 2022 Q3 2021 % CHF % LC2 9M 2022 9M 2021 % CHF % LC2 Market Dynamics Sales 509 436 + 17 + 24 1 626 1 224 + 33 + 37 – Global industrial markets normalized; consumer EBITDA 115 96 + 20 378 252 + 50 m

  12. Slide 12: Third Quarter 2022 – Catalysis

    12 Third Quarter / Nine Month Figures 2022 27.10.2022 Third Quarter 2022 – Catalysis1 in CHF m Q3 2022 Q3 2021 % CHF % LC2 9M 2022 9M 2021 % CHF % LC2 Market Dynamics Sales 262 216 + 21 + 28 679 630 +8 + 12 – Continued demand for more sustainable EBITDA 30 26 + 15 57 106 - 46 solutions and continued

  13. Slide 13: Third Quarter 2022 – Natural Resources

    13 Third Quarter / Nine Month Figures 2022 27.10.2022 Third Quarter 2022 – Natural Resources1 in CHF m Q3 2022 Q3 2021 % CHF % LC2 9M 2022 9M 2021 % CHF % LC2 Market Dynamics Sales 541 444 + 22 + 30 1 570 1 276 + 23 + 28 – Softening demand in global industrial sector EBITDA 108 78 + 38 298 216 + 38

  14. Slide 14: Outlook Q4 2022

    14 Third Quarter / Nine Month Figures 2022 27.10.2022 Outlook Q4 2022 Care Chemicals Catalysis Natural Resources Group Q4 2022 Outlook: Q4 2022 Outlook: Q4 2022 Outlook: Q4 2022 Outlook: − Solid y-o-y sales growth in − Solid y-o-y and sequential − Solid y-o-y sales growth in − Solid LC1 sales LC,1 d

  15. Slide 15: Outlook FY 2022

    CLARIANT™ Outlook FY 2022 what is precious to you?

  16. Slide 16: Full Year Outlook 2022 – Strong Sales Growth and Underlying EBITDA Margin Improvement

    16 Third Quarter / Nine Month Figures 2022 27.10.2022 Full Year Outlook 2022 – Expect Strong Sales Growth and Underlying EBITDA Margin Improvement, Reported EBITDA Impacted by One-offs External Factors FY 2022 Group Internal Factors − Geopolitical conflict impacting global • Strong sales growth in L

  17. Slide 17: Backup Slides

    Backup Slides Third Quarter / Nine Month Figures 2022

  18. Slide 18: Third Quarter 2022 – Sales and EBITDA by Business Area

    18 Third Quarter / Nine Month Figures 2022 27.10.2022 Third Quarter 2022 – Sales and EBITDA by Business Area Sales EBITDA 20212 in CHF m 2022 2021 % LC1 2022 % CHF (restated) Care Chemicals 509 436 + 24 % 115 96 + 20 % margin 22.6 % 22.0 % Catalysis 262 216 + 28 % 30 26 + 15 % margin 11.5 % 12.0 % N

  19. Slide 19: Nine Month 2022 – Group Overview

    19 Third Quarter / Nine Month Figures 2022 27.10.2022 Nine Month 2022 – Group1 Overview Geographic split – European sales growth supported by strong growth in Care Chemicals (Consumer Care and Industrial Applications) and Natural Resources (all Business Units) Sales CHF 3 875 m Emerging markets Matu

  20. Slide 20: Nine Month 2022 – Sales and EBITDA by Business Area

    20 Third Quarter / Nine Month Figures 2022 27.10.2022 Nine Month 2022 – Sales and EBITDA by Business Area Sales to third parties EBITDA 20212 in CHF m 2022 2021 % LC1 2022 % CHF (restated) Care Chemicals 1 626 1 224 + 37 % 378 252 + 50 % margin 23.2 % 20.6 % Catalysis 679 630 + 12 % 57 106 - 46 % ma

  21. Slide 21: Natural Gas – Global Footprint of Specialty Chemicals Exposure

    21 Third Quarter / Nine Month Figures 2022 27.10.2022 Natural Gas – Global Footprint of Specialty Chemicals Exposure Nine Month 2022 Regional Production vs. Regional Consumption Regional Production1 Split Energy Cost as % of… 7.4 in tons 4.3 4.9 5.2 Asia-Pacific Europe, Middle East & Africa 32 % Sal

  22. Slide 22: Calendar of Upcoming Corporate Events

    22 Third Quarter / Nine Month Figures 2022 27.10.2022 Calendar of Upcoming Corporate Events 02 March 2023 Fourth Quarter / Full Year 2022 Reporting 09 March 2023 Integrated Report 2022 04 April 2023 Annual General Meeting 05 May 2023 First Quarter 2023 Reporting 28 July 2023 Second Quarter / Half Ye

  23. Slide 23: IR Contacts

    23 Third Quarter / Nine Month Figures 2022 27.10.2022 IR Contacts Andreas Schwarzwälder Phone: +41 61 469 63 73 Head of Investor Relations Email: investor-relations@clariant.com Maria Ivek Senior Investor Relations Officer Alexander Kamb Investor Relations Officer

Clariant — Q3 2022 Earnings Presentation on 6ix